First Manhattan’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$32M Sell
90,909
-2,024
-2% -$722K 0.09% 88
2025
Q4
$30.4M Sell
92,933
-3,113
-3% -$987K 0.08% 95
2025
Q3
$27.1M Sell
96,046
-354
-0.4% -$103K 0.07% 97
2025
Q2
$26.9M Sell
96,400
-1,936
-2% -$548K 0.08% 97
2025
Q1
$30.6M Sell
98,336
-3,414
-3% -$1.01M 0.09% 84
2024
Q4
$26.5M Sell
101,750
-11,040
-10% -$3.28M 0.08% 92
2024
Q3
$36.3M Sell
112,790
-1,179
-1% -$386K 0.11% 76
2024
Q2
$35.6M Sell
113,969
-5,513
-5% -$1.62M 0.11% 77
2024
Q1
$34M Sell
119,482
-3,013
-2% -$882K 0.11% 75
2023
Q4
$34.9M Sell
122,495
-4,144
-3% -$1.13M 0.12% 71
2023
Q3
$33.7M Sell
126,639
-3,325
-3% -$830K 0.12% 70
2023
Q2
$28.5M Sell
129,964
-5,844
-4% -$1.36M 0.1% 82
2023
Q1
$32.3M Sell
135,808
-3,974
-3% -$976K 0.12% 75
2022
Q4
$36M Sell
139,782
-4,478
-3% -$1.2M 0.13% 70
2022
Q3
$31.9M Sell
144,260
-6,962
-5% -$1.69M 0.14% 72
2022
Q2
$36.1M Sell
151,222
-10,586
-7% -$2.59M 0.15% 68
2022
Q1
$39.1M Buy
161,808
+9,437
+6% +$2.17M 0.13% 75
2021
Q4
$34.3M Buy
152,371
+1,711
+1% +$361K 0.11% 81
2021
Q3
$32M Sell
150,660
-216,607
-59% -$49.9M 0.12% 82
2021
Q2
$89.5M Sell
367,267
-7,269
-2% -$1.79M 0.33% 50
2021
Q1
$93.2M Buy
374,536
+898
+0.2% +$214K 0.4% 45
2020
Q4
$85.9M Buy
373,638
+155,186
+71% +$35.8M 0.41% 43
2020
Q3
$55.5M Sell
218,452
-3,976
-2% -$985K 0.29% 51
2020
Q2
$52.5M Sell
222,428
-1,916
-0.9% -$437K 0.3% 52
2020
Q1
$45.5M Sell
224,344
-608
-0.3% -$133K 0.29% 52
2019
Q4
$54.2M Sell
224,952
-6,698
-3% -$1.48M 0.27% 59
2019
Q3
$44.8M Sell
231,650
-171
-0.1% -$32.8K 0.25% 65
2019
Q2
$42.7M Sell
231,821
-5,914
-2% -$1.06M 0.24% 65
2019
Q1
$45.2M Sell
237,735
-1,305
-0.5% -$249K 0.26% 60
2018
Q4
$46.5M Sell
239,040
-69,919
-23% -$13.6M 0.29% 57
2018
Q3
$64M Sell
308,959
-35,628
-10% -$7.02M 0.34% 48
2018
Q2
$63.6M Sell
344,587
-17,901
-5% -$3.17M 0.37% 50
2018
Q1
$61.8M Sell
362,488
-1,902
-0.5% -$349K 0.35% 55
2017
Q4
$63.4M Sell
364,390
-50,811
-12% -$8.99M 0.35% 56
2017
Q3
$77.4M Sell
415,201
-18,275
-4% -$3.24M 0.44% 38
2017
Q2
$74.7M Buy
433,476
+4,758
+1% +$774K 0.44% 42
2017
Q1
$70.3M Buy
428,718
+16,877
+4% +$2.8M 0.42% 46
2016
Q4
$60.2M Buy
411,841
+147,542
+56% +$22.2M 0.37% 48
2016
Q3
$44.1M Sell
264,299
-755
-0.3% -$128K 0.27% 71
2016
Q2
$40.3M Sell
265,054
-945
-0.4% -$147K 0.25% 72
2016
Q1
$39.9M Buy
265,999
+2,500
+0.9% +$371K 0.25% 68
2015
Q4
$42.8M Sell
263,499
-972
-0.4% -$153K 0.26% 68
2015
Q3
$36.6M Sell
264,471
-15,542
-6% -$2.45M 0.24% 72
2015
Q2
$43M Sell
280,013
-5,280
-2% -$846K 0.25% 73
2015
Q1
$45.6M Sell
285,293
-3,499
-1% -$551K 0.26% 69
2014
Q4
$46M Sell
288,792
-12,275
-4% -$1.91M 0.26% 76
2014
Q3
$42.3M Buy
301,067
+1,539
+0.5% +$201K 0.25% 76
2014
Q2
$35.5M Buy
299,528
+1,267
+0.4% +$147K 0.22% 85
2014
Q1
$36.8M Buy
298,261
+4,976
+2% +$603K 0.24% 82
2013
Q4
$33.5M Sell
293,285
-6,218
-2% -$707K 0.22% 84
2013
Q3
$33.5M Sell
299,503
-97
-0% -$10.5K 0.23% 76
2013
Q2
$32.8M Buy
+299,600
New +$31.1M 0.23% 79

Other funds holding AMGN

First Manhattan's AMGN Position: Q1 2026 in Review

First Manhattan reduced its Amgen (AMGN) stake by 2.2% in Q1 2026, selling an estimated $722K and leaving 90,909 shares worth $32M. The position accounts for 0.09% of the portfolio, ranked #88.

First Manhattan first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $93.2M in Q1 2021. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • First Manhattan held 90,909 shares of Amgen worth $32M as of Q1 2026.
  • First Manhattan sold 2,024 Amgen shares in Q1 2026, an estimated $722K.
  • Amgen made up 0.09% of First Manhattan's portfolio in Q1 2026, its #88 holding.
  • First Manhattan first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • First Manhattan's Amgen position peaked at $93.2M in Q1 2021.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on First Manhattan's 13F filing for Q1 2026, filed 15 May 2026.